RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-952
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1107100; Gene model (P.falciparum): PF3D7_0507500; Gene product: subtilisin-like protease 1 (SUB1)
Details mutation: The mutant contains a FRTed ORF of the sub1 locus
Details conditional mutagenesis: The ORF of sub1 is removed in the sporozoite stage by the Flp/FRT system.
Transgene
Transgene not Plasmodium: Flp recombinase of yeast (Flp)
Promoter: Gene model: PBANKA_0501200; Gene model (P.falciparum): Not available; Gene product: early transcribed membrane protein up-regulated in infective sporozoites
3'UTR: Gene model: PBANKA_1349800; Gene product: sporozoite surface protein 2 thrombospondin-related anonymous protein (sporozoite surface protein 2; SSP2; SSP-2)
Insertion locus: Gene model: PBANKA_0501200; Gene product: early transcribed membrane protein up-regulated in infective sporozoites
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0711900; Gene product: heat shock protein 70 (HSP70)
Insertion locus: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Phenotype Liver stage;
Last modified: 22 December 2013, 21:26
  *RMgm-952
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 24089525
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei NK65
Name parent line/clone RMgm-269
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherL. Tawk, R. Menard, JC Barale
Name Group/DepartmentUnité de Biologie et Génétique du Paludisme
Name InstituteInstitut Pasteur
CityParis
CountryFrance
Name of the mutant parasite
RMgm numberRMgm-952
Principal nameSUB1/Cond
Alternative nameClone SUB1/Cond-5
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stagePCR analysis of genomic DNA of the mutant sporozoites showed high levels (>90%) of SSR (site-specific recombination) in salivary gland sporozoites, which resulted in the removal of the FRTed ORF of SUB1.
The mutant sporozoites showed an infectivity to HepG2 cells that was comparable to wild type parasites and produced liver stages at 24 and 48 hour after incubation of mutant sporozoites with HepG2 cells that were comparable in number and size to that of wild type sporozoites.
Evidence is presented for normal development of liver merozoites but a reduced egress of liver merozoites from the mature liver schizonts. Evidence is presented that the reduced egress is due to lack of rupture of the PVM indicating a role of SUB1 in PVM rupture. in addition, evidence is presented for a role of SUB1 in processing of SERA3 and MSP1. SUB1-deficient liver stage merozoites are unable to establish a blood stage infection.
Additional remarks phenotype

Mutant/mutation
The mutant is a 'Flp/FRT conditional knock-out mutant' of SUB1 (subtilisin-like protease 1). The mutant expresses the yeast Flp recombinase under the control of the uis4 promoter  and contains a FRTed ORF (open reading frame) of the sub1 locus. In addition it expresses GFP under the control of the hsp70 promoter. The gfp gene is stably integrated into the genome. This mutant has been generated by replacement of the endogenous sub1 gene by an sub1 gene with a FRTed ORF in the mutant RMgm-269 that expresses Flp and GFP.
The sub1 ORF is removed from the genome by using the Flp/FRT site-specific recombination (SSR) system (see RMgm-269). Removal of the FRTed ORF of sub1  has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase in sporozoites that resulted in the excision of the ORF of sub1 which was flanked by FRT sequences.

Protein (function)
The subtilisin-like protease SUB1, a bacterial-like serine protease, is a Plasmodium merozoite product essential for the parasite erythocytic cycle. In P. falciparum, SUB1 was shown to have a dual function. It is crucial for merozoite egress from erythrocytes and renders released merozoites competent for a new round of erythrocyte invasion. In the process of P.falciparum merozoite egress from erythrocytes, SUB1 carries out the maturation of the family of papain-like proteases called serine repeat antigens (SERAs). It remains unknown whether the SERAs have a direct role in membrane disruption, or whether they in turn maturate other effectors, but it is established that their SUB1-dependent maturation is essential for the egress of merozoite. The reported role of SUB1 in P.falciparum merozoite invasion is to undertake the processing of merozoite surface proteins (MSPs), including MSP1. After SUB1 maturation, the membrane-anchored Cterminal 42-kDa fragment of MSP1, remains associated with the other MSP1 fragments and additional partners, including MSP6 and MSP7.

Phenotype
The Flp/FRT site-specific recombination (SSR) system of yeast has been used to silence SUB1 expression specifically in liver stages. Removal of the FRTed ORF of sub1  has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase in sporozoites that resulted in the excision of the FRTed ORF of sub1.

PCR analysis of genomic DNA of the mutant sporozoites showed high levels (>90%) of SSR (site-specific recombination) in salivary gland sporozoites, which resulted in the removal of the FRTed ORF of SUB1.
The mutant sporozoites showed an infectivity to HepG2 cells that was comparable to wild type parasites and produced liver stages at 24 and 48 hour after incubation of mutant sporozoites with HepG2 cells that were comparable in number and size to that of wild type sporozoites.
Evidence is presented for normal development of liver merozoites but a reduced egress of liver merozoites from the mature liver schizonts. Evidence is presented that the reduced egress is due to lack of rupture of the PVM indicating a role of SUB1 in PVM rupture. in addition, evidence is presented for a role of SUB1 in processing of SERA3 and MSP1. SUB1-deficient liver stage merozoites are unable to establish a blood stage infection.

Additional information
See also RMgm-972 for an independent mutant containing a FRTed ORF of the sub1 locus. Analyses of liver stages of this mutant provided evidence for the following: 48 hour mutant liver stages were significantly smaller than wild type liver stages. The majority of the PbSUB1-deficient parasites completely lacked a detectable MSP1 signal. Multiple nuclei were observed in the early PbSUB1-deficient schizonts, indicating normal nuclear replication, but in later stages many of the schizont nuclei appeared condensed and abnormal. Mutant liver stages were deficient in merosome formation. SUB1-deficient liver stages are unable to establish a blood stage infection.

Other mutants
RMgm-972: An independent mutant containing a FRTed ORF of the sub1 locus
RMgm-973: A mutant expressing a HA-tagged version of SUB1


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1107100
Gene Model P. falciparum ortholog PF3D7_0507500
Gene productsubtilisin-like protease 1
Gene product: Alternative nameSUB1
Details of the genetic modification
Short description of the mutationThe mutant contains a FRTed ORF of the sub1 locus
Inducable system usedFlp/FRT
Short description of the conditional mutagenesisThe ORF of sub1 is removed in the sporozoite stage by the Flp/FRT system.
Additional remarks inducable system
Click to view information
Click to hide information
This mutant has been generated by replacement of the endogenous sub1 gene by an sub1 gene with a FRTed ORF in mutant RMgm-269 that expresses Flp and GFP. Removal of the FRTed ORF of sub1 has been achieved by transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase in sporozoites that resulted in the excision of the ORF of sub1 which was flanked by FRT sequences.
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedureWR99210
Selection (negative) procedureNo
Additional remarks genetic modificationThe plasmid pSUB1/FRT was designed to place, following double cross-over recombination, a 5’ FRT site 736 bp upstream from the sub1 start codon and a 3’ FRT site downstream from the 3’ UTR of sub1 and the selectable marker.
The targeting pSUB1/FRT plasmid was constructed by cloning three PCR products into a plasmid that carries two Flp recognition target (FRT) sites and the human dihydrofolate reductase (hDHFR) expression cassette i) a 736 bp fragment upstream the Pbsub1 locus; ii) a 3479bp DNA fragment encompassing the 5’ FRT site, 1177bp corresponding to the 5’ UnTranslated Region (UTR) of Pbsub1, the complete PbSUB1 open reading frame (1799 bp) and 503 bp corresponding to Pbsub1 3’ UTR and iii) a 673 bp fragment downstream the Pbsub1 locus. The latter was amplified using the oligonucleotides 5’-CCCGGGCATTTGGTGTATATTATTGTTTTTCTTG-3’ and 5’-GGTACCTCAATGTGCATTTATTGTTATGC-3’ and was cloned first in the plasmid using SmaI and KpnI restriction sites. To the resulting plasmid was added the 736 bp fragment upstream the Pbsub1 locus amplified using the primers 5’-AAGCTTTAAATAAATCACCAAATATTA
AATTGG-3’ and 5’-GCGGCCGCATGTGTGTTATATAAGTGATTATTCTTTAAGC-3’ using HindIII and NotI restriction sites. Finally, the entire Pbsub1 locus was amplified using the 5’-GATATCTAAATCGAAGAAAATATAAACATTCG-3’ and 5’-GGGCCCAAATATATGTCGGTGTAATGCACC-3’ primers and cloned using the EcoRV and ApaI restriction sites.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameFlp recombinase of yeast (Flp)
Details of the genetic modification
Inducable system usedFlp/FRT
Additional remarks inducable system The mutant expresses the yeast Flp recombinase under the control of the promoter of uis4. The mutant does not contain the hdhfr selectable marker that has been used to introduce the flp gene. This marker has been removed from the genome by using the Flp/FRT site-specific recombination (SSR) system. Removal of the hdhfr gene has been achieved by transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase that resulted in the excision of the hdhfr gene that was flanked by FRT sequences.
Type of plasmid/constructPlasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe flpl gene was cloned between 1.5 kb of 5′ regulatory sequence of uis4 and 0.6 kb of 3′ regulatory sequence of trap. The plasmid was linearized in the 5′ uis4 regulatory sequence to direct gap repair and plasmid integration by single crossover recombination at the homologous chromosomal locus, leaving the endogenous uis4 gene intact. The plasmid contained the hdhfr selectable marker that is flanked with the 34bp FRT sequences. The mutant expresses the yeast Flp recombinase under the control of the promoter of uis4. The mutant does not contain the hdhfr selectable marker that has been used to introduce the flp gene. This marker has been removed from the genome by using the Flp/FRT site-specific recombination (SSR) system. Removal of the hdhfr gene has been achieved by transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase that resulted in the excision of the hdhfr gene that was flanked by FRT sequences. In the resulting mutant (UIS4/Flp(-), by integrating at the DHFR-TS locus, a gfp gene under control of the hsp70 promoter was integrated into the dhfr/ts locus, using a construct that contains the pyrimethamine resistant pbdhfr-ts gene.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0501200
Gene Model P. falciparum ortholog Not available
Gene productearly transcribed membrane protein up-regulated in infective sporozoites
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 15'-GCGCCCCGGGTGTGATAGTGTAGATTTTTTTGTTTGACCATTG-3'
Additional information primer 15'- GCGCCCATGGTTTATTCAGACGTAATAATTATGTGCTGAAAGG-3'
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1349800
Gene productsporozoite surface protein 2 thrombospondin-related anonymous protein
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_0501200
Gene productearly transcribed membrane protein up-regulated in infective sporozoites
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitepbdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe flpl gene was cloned between 1.5 kb of 5′ regulatory sequence of uis4 and 0.6 kb of 3′ regulatory sequence of trap. The plasmid was linearized in the 5′ uis4 regulatory sequence to direct gap repair and plasmid integration by single crossover recombination at the homologous chromosomal locus, leaving the endogenous uis4 gene intact. The plasmid contained the hdhfr selectable marker that is flanked with the 34bp FRT sequences. The mutant expresses the yeast Flp recombinase under the control of the promoter of uis4. The mutant does not contain the hdhfr selectable marker that has been used to introduce the flp gene. This marker has been removed from the genome by using the Flp/FRT site-specific recombination (SSR) system. Removal of the hdhfr gene has been achieved by transmission of the mutant through mosquitoes, thereby activating expression of the Flp recombinase that resulted in the excision of the hdhfr gene that was flanked by FRT sequences. In the resulting mutant (UIS4/Flp(-), by integrating at the DHFR-TS locus a gfp gene under control of the hsp70 promoter was integrated into the dhfr/ts locus, using a construct that contains a pyrimethamine resistant pbdhfr-ts gene.

To make a GFP expression cassette driven by the hsp70 promoter, the 1.2 kb upstream region and 1.0 kb downstream region of hsp70 were ligated to either side of the GFP coding sequence. To make a targeted insertion vector, this expression cassette was ligated into the downstream region of the pyrimethamine-resistant pbdhfr-ts gene
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0711900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4